2024-2032 年按产品、应用（低丙种球蛋白血症、慢性发炎性脱髓鞘性多发性神经病变、免疫缺陷症、重症肌无力等）、分娩方式和地区分類的免疫球蛋白市场报告

IMARC Group年全球免疫球蛋白市场规模达157亿美元。

免疫球蛋白也称为抗体，是指由血浆或白血球 (WBC) 产生的一类糖蛋白分子。它们通常存在于免疫系统的血清和细胞中，并透过明确识别和结合抗原（例如细菌或病毒）而发挥抗体的作用，并帮助破坏它们。他们的检验帮助医生诊断免疫缺陷、过敏和自体免疫疾病，如幼年特发性关节炎、红斑性狼疮和乳糜泻。目前，世界各地有不同类别的免疫球蛋白，取决于生物学特征、结构、标靶特异性和分布。

免疫球蛋白市场趋势：

由于快速的城市化和繁忙的日程安排，个人速食消费量有所增加。再加上久坐的生活方式以及患有多发性骨髓瘤、华氏巨球蛋白血症和自体免疫疾病等疾病的患者数量不断增加，是推动市场成长的主要因素之一。此外，人们对早期诊断的认识不断提高，以及对个人化药物的偏好不断增加，也促进了市场的成长。而且，免疫球蛋白透过多种给药途径帮助人体对抗各种传染病。因此，随着冠状病毒病（COVID-19）住院患者数量的不断增加以及迫切需要有效的治疗方法来防止大流行的传播，超免疫球蛋白被用作控制感染的有效药物。除此之外，一些製药公司正在推出新型和先进的免疫球蛋白，以提高治疗神经系统疾病的效率。其他因素，例如增加研发 (R&D) 专案资金和改善医疗基础设施等，预计将在未来几年进一步推动市场成长。

本报告回答的关键问题

• 2023年全球免疫球蛋白市场规模有多大？ 2024-2032年全球免疫球蛋白市场的预期成长率是多少？
• 推动全球免疫球蛋白市场的关键因素是什么？
• COVID-19 对全球免疫球蛋白市场有何影响？
• 根据应用，全球免疫球蛋白市场的细分如何？
• 根据交付方式，全球免疫球蛋白市场的细分情况如何？
• 全球免疫球蛋白市场的关键区域有哪些？
• 谁是全球免疫球蛋白市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

• 研究目的
• 利害关係人
• 数据来源
  • 主要来源
  • 二手资料
• 市场预测
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第 3 章：执行摘要

第 4 章：简介

• 概述
• 主要行业趋势

第 5 章：全球免疫球蛋白市场

• 市场概况
• 市场表现
• COVID-19 的影响
• 市场预测

第 6 章：市场区隔：依产品

• 免疫球蛋白G
  • 市场趋势
  • 市场预测
• 免疫球蛋白A
  • 市场趋势
  • 市场预测
• 免疫球蛋白M
  • 市场趋势
  • 市场预测
• 免疫球蛋白E
  • 市场趋势
  • 市场预测
• 免疫球蛋白D
  • 市场趋势
  • 市场预测

第 7 章：市场区隔：按应用

• 低丙种球蛋白血症
  • 市场趋势
  • 市场预测
• 慢性发炎性脱髓鞘多发性神经病变 (CIDP)
  • 市场趋势
  • 市场预测
• 免疫缺陷症
  • 市场趋势
  • 市场预测
• 重症肌无力
  • 市场趋势
  • 市场预测
• 其他的
  • 市场趋势
  • 市场预测

第 8 章：市场区隔：依交付方式

• 静脉给药方式
  • 市场趋势
  • 市场预测
• 皮下给药方式
  • 市场趋势
  • 市场预测

第 9 章：市场区隔：按地区

• 北美洲
  • 美国
  • 加拿大
• 亚太
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他的
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他的
• 中东和非洲
  • 市场趋势
  • 市场细分：按国家/地区
  • 市场预测

第 10 章：SWOT 分析

• 概述
• 优势
• 弱点
• 机会
• 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

• 概述
• 买家的议价能力
• 供应商的议价能力
• 竞争程度
• 新进入者的威胁
• 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

• 市场结构
• 关键参与者
• 关键参与者简介
  • ADMA Biologics Inc.
  • Baxter international Inc.
  • Biotest AG
  • CSL Limited
  • Grifols SA
  • Kedrion SpA
  • LFB SA
  • Octapharma AG
  • Sanquin Plasma Products BV
  • Takeda Pharmaceutical Company Limited

The global immunoglobulin market size reached US$ 15.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.

Also known as antibodies, immunoglobulins refer to a class of glycoprotein molecules produced by plasma or white blood cells (WBCs). They are generally present in the serum and cells of the immune system and function as antibodies by explicitly recognizing and binding antigens, such as bacteria or viruses, and aiding in their destruction. Their tests help doctors diagnose immunodeficiencies, allergies, and autoimmune conditions like juvenile idiopathic arthritis, lupus, and celiac disease. At present, different classes of immunoglobulins are available around the world depending on biological features, structure, target specificity, and distribution.

Immunoglobulin Market Trends:

Due to rapid urbanization and hectic schedules, there is a rise in the consumption of fast food among individuals. This, along with sedentary lifestyles and the increasing number of patients with medical conditions like multiple myeloma, Waldenstrom macroglobulinemia, and autoimmune disorders, represents one of the primary factors impelling the growth of the market. Additionally, rising awareness about early diagnosis and the increasing preferences for personalized medicines are contributing to market growth. Moreover, immunoglobulins through a variety of routes of administration help the body fight various infectious diseases. As a result, with the rising number of hospitalized patients with coronavirus disease (COVID-19) and an urgent need for effective therapies to prevent the spread of the pandemic, hyperimmune globulin is utilized as an effective medicine in managing the infection. Apart from this, several pharmaceutical companies are introducing new and advanced immunoglobulins with improved efficiency for the treatment of neurological disorders. Other factors, such as increasing funding for research and development (R&D) projects and the improving healthcare infrastructure are anticipated to propel the market growth further in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunoglobulin market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and mode of delivery.

Breakup by Product:

IgG

IgA

IgM

IgE

IgD

Breakup by Application:

Hypogammaglobulinemia

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Immunodeficiency Disease

Myasthenia Gravis

Others

Breakup by Mode of Delivery:

Intravenous Mode of Delivery

Subcutaneous Mode of Delivery

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics Inc., Baxter international Inc., Biotest AG, CSL Limited, Grifols S.A, Kedrion S.p.A, LFB SA, Octapharma AG, Sanquin Plasma Products B.V. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report

• 1. What was the size of the global immunoglobulin market in 2023?
• 2. What is the expected growth rate of the global immunoglobulin market during 2024-2032?
• 3. What are the key factors driving the global immunoglobulin market?
• 4. What has been the impact of COVID-19 on the global immunoglobulin market?
• 5. What is the breakup of the global immunoglobulin market based on the application?
• 6. What is the breakup of the global immunoglobulin market based on the mode of delivery?
• 7. What are the key regions in the global immunoglobulin market?
• 8. Who are the key players/companies in the global immunoglobulin market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Immunoglobulin Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 IgG
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 IgA
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 IgM
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 IgE
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 IgD
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Application

• 7.1 Hypogammaglobulinemia
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Immunodeficiency Disease
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Myasthenia Gravis
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Mode of Delivery

• 8.1 Intravenous Mode of Delivery
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Subcutaneous Mode of Delivery
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 ADMA Biologics Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
  • 14.3.2 Baxter international Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Biotest AG
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 CSL Limited
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Grifols S.A
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Kedrion S.p.A
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 LFB SA
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Octapharma AG
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 SWOT Analysis
  • 14.3.9 Sanquin Plasma Products B.V.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Takeda Pharmaceutical Company Limited
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis

List of Figures

• Figure 1: Global: Immunoglobulin Market: Major Drivers and Challenges
• Figure 2: Global: Immunoglobulin Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Immunoglobulin Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Immunoglobulin Market: Breakup by Product (in %), 2023
• Figure 5: Global: Immunoglobulin Market: Breakup by Application (in %), 2023
• Figure 6: Global: Immunoglobulin Market: Breakup by Mode of Delivery (in %), 2023
• Figure 7: Global: Immunoglobulin Market: Breakup by Region (in %), 2023
• Figure 8: Global: Immunoglobulin (IgG) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 9: Global: Immunoglobulin (IgG) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 10: Global: Immunoglobulin (IgA) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 11: Global: Immunoglobulin (IgA) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 12: Global: Immunoglobulin (IgM) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Immunoglobulin (IgM) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 14: Global: Immunoglobulin (IgE) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 15: Global: Immunoglobulin (IgE) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 16: Global: Immunoglobulin (IgD) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: Immunoglobulin (IgD) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 18: Global: Immunoglobulin (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: Immunoglobulin (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 22: Global: Immunoglobulin (Immunodeficiency Disease) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 23: Global: Immunoglobulin (Immunodeficiency Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 24: Global: Immunoglobulin (Myasthenia Gravis) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 25: Global: Immunoglobulin (Myasthenia Gravis) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 26: Global: Immunoglobulin (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 27: Global: Immunoglobulin (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 28: Global: Immunoglobulin (Intravenous Mode of Delivery) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 29: Global: Immunoglobulin (Intravenous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 32: North America: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 33: North America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 34: United States: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 35: United States: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 36: Canada: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: Canada: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: Asia-Pacific: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: Asia-Pacific: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: China: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: China: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: Japan: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: Japan: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: India: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: India: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: South Korea: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 47: South Korea: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 48: Australia: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 49: Australia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 50: Indonesia: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 51: Indonesia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 52: Others: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 53: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 54: Europe: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 55: Europe: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 56: Germany: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 57: Germany: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 58: France: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 59: France: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 60: United Kingdom: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 61: United Kingdom: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 62: Italy: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 63: Italy: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Spain: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 65: Spain: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 66: Russia: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 67: Russia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Others: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 69: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 70: Latin America: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 71: Latin America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 72: Brazil: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 73: Brazil: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 74: Mexico: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 75: Mexico: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 76: Others: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 77: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 78: Middle East and Africa: Immunoglobulin Market: Sales Value (in Million US$), 2018 & 2023
• Figure 79: Middle East and Africa: Immunoglobulin Market: Breakup by Country (in %), 2023
• Figure 80: Middle East and Africa: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 81: Global: Immunoglobulin Industry: SWOT Analysis
• Figure 82: Global: Immunoglobulin Industry: Value Chain Analysis
• Figure 83: Global: Immunoglobulin Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Immunoglobulin Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Immunoglobulin Market Forecast: Breakup by Product (in Million US$), 2024-2032
• Table 3: Global: Immunoglobulin Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 4: Global: Immunoglobulin Market Forecast: Breakup by Mode of Delivery (in Million US$), 2024-2032
• Table 5: Global: Immunoglobulin Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: Immunoglobulin Market: Competitive Structure
• Table 7: Global: Immunoglobulin Market: Key Players